CEDRUS INVESTMENTS HOSTED LIFE SCIENCES LUNCHEON IN SHANGHAI, 13TH NOVEMBER 2017

SHANGHAI, 14th November 2017 – Cedrus Investments (“Cedrus”), a global boutique
investment firm, hosted the second meeting of the life sciences luncheon series for this year on Monday, 13th November 2017 in Shanghai at the St. Regis Shanghai Jingan. Mr. Randy Hice, Cedrus’ Chief Technical Officer and Member of the Life Sciences Advisory Board, shared with institutional investors, venture capitalists, and company executives his insights on two crucial themes in biotechnology: “New Frontiers in Immunology R&D” and “Increasing Laboratory Productivity and Meeting FDA Compliance through Software”.
Mr. Hice is recognized globally as a leading authority in laboratory informatics and the most published author in the world on topics of complex laboratory automation and workflow analysis. His recent positions included the CEO of Laboratory Expertise Center, Inc. and Manager of Global Strategy at Abbott Informatics, a division of Abbott Laboratories.

 

The event was well received, and elicited high-level discussion in the Q&A session following Mr. Hice’s speech. Investors thought that it was especially important to understand the very latest developments in the biotech industry, as well as the overseas regulatory environment in order to conform to international conventions. Those attended the luncheon included executives from Fountainvest Partners, Franklin Templeton Sealand, Qiming VC, and SAIF Partners.
Cedrus’ Chief Technical Officer, Mr. Randy Hice said, “I am glad to be able to share the
latest trends in immunology research and development with investors and companies, as well as providing some perspectives on how progressive scientific enterprises are utilizing the latest tools available to improve their data quality while achieving FDA compliance. The feedback from the event’s participants provided us with a better understanding of the active areas of interest from Chinese life sciences investors and companies, and that understanding will no doubt facilitate future cooperation regarding cross-border transactions and investment opportunities.”
Cedrus’ Chairman, Mr. Rani Jarkas said, “With its particular focus on the Greater China region, Cedrus has always positioned itself as a leader in fulfilling the needs of the investment community and companies around the world. Given our global network and expertise in the life sciences industry, we can serve as the platform for both investors and companies worldwide, facilitating both inbound and outbound investments for the Chinese and other geographical markets.”

 

#RaniJarkas, #CedrusInvestments

 

Advertisements

Rani Jarkas – Cedrus Investments’ Head of Life Sciences Ms. Kimberly Nearing Presented at the Chengdu Global Innovation and Entrepreneurship Fair 2017 in Chengdu, China

Cedrus Investments’ Head of Life Sciences Ms. Kimberly Nearing Presented at the Chengdu Global Innovation and Entrepreneurship Fair 2017 in Chengdu, China

The Managing Director, Head of Life Sciences at Cedrus Investments (“Cedrus”), Ms. Kimberly Nearing, was invited by the Chengdu Municipal People’s Government to participate in its Global Innovation and Entrepreneurship fair.

Rani Jarkas, the Chairman of Cedrus Investments.

Rani Jarkas is a highly experienced financial services executive, with over 20 years of international banking experience. Currently, Mr. Jarkas is the Chairman of Cedrus Investments, a global boutique investment firm. Cedrus’ domain expertise is in life sciences, natural resources, energy, cleantech and nanotechnology. – Rani Jarkas

Read Full Story

王雷(Rani Jarkas):中国A股将被纳入MSCI新兴市场指数

摩根士丹利资本国际公司(MSCI Inc.)于本月20日宣布从2018年6月开始将中国A股纳入MSCI新兴市场和全球基准指数(ACWI)。

MSCI新兴市场指数是全球范围内最为广泛认可的新兴市场股票表现衡量工具。该指数跟踪记录了23个经济体的超过800只股票,其中超过70%都在亚洲

大约17万亿美元的全球资产都以MSCI新兴市场指数为基准。A股被纳入指数后,海外投资者将会开始购买这些股票,这必然将会引领A股市场的强势上涨,上周一总部位于上海的澎湃新闻报道到。

全球精品投资公司赛德思投资在香港、上海、北京均设有办公室,董事长王雷(Rani Jarkas)表示:“MSCI决定将A股纳入指数表明中国经济正在稳步增长,并且潜力巨大。随着越来越多的国际资本流入,A股市场将不再由本土投资者控制,中国大陆股票市场的金融产品将会更丰富。”

Rani Jarkas, the Chairman of Cedrus Investments.

Rani Jarkas is a highly experienced financial services executive, with over 20 years of international banking experience. Currently, Mr. Jarkas is the Chairman of Cedrus Investments, a global boutique investment firm. Cedrus’ domain expertise is in life sciences, natural resources, energy, cleantech and nanotechnology. – Rani Jarkas